Physician profile
Mark J Fallen
NPI 1699789719
$4,673.78
in general payments reported to CMS, 2019-2025
37 companies · $203 in 2025
The $203 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $924 · 2020: $373 · 2021: $701 · 2022: $1,276 · 2023: $568 · 2024: $630 · 2025: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,366 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.73 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,290.11 | 2019-2025 | General - Kidney Stone Disease, Lithovue, Flexiva |
| Axonics, INC. | $493.43 | 2020-2024 | Axonics |
| Coloplast Corp | $331.60 | 2019-2024 | Speedicath |
| Srs Medical Systems, INC. | $292.61 | 2021-2022 | |
| Olympus America INC. | $279.81 | 2019-2024 | Itind System |
| Teleflex LLC | $279.00 | 2022 | |
| Dendreon Pharmaceuticals LLC | $218.16 | 2019-2024 | Provenge |
| Neotract INC. | $217.73 | 2019-2020 | |
| Antares Pharma, INC. | $151.33 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Conmed Corporation | $138.08 | 2023 | Airseal |
| Agiliti Surgical, INC. | $129.62 | 2023 | Sonablate |
| Ethicon INC. | $118.04 | 2019 | |
| Convatec INC. | $69.66 | 2022-2023 | |
| Abbvie INC. | $65.78 | 2019-2023 | |
| Telix Pharmaceuticals | $48.46 | 2024 | Illuccix |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dornier Medtech America, INC | $45.87 | 2019 | |
| Myovant Sciences INC. | $39.19 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $38.31 | 2023-2024 | Pylarify |
| Halozyme INC | $37.28 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Accord Healthcare, INC. | $33.81 | 2023 | |
| Janssen Biotech, INC. | $32.38 | 2019-2024 | Erleada, Akeega, Balversa |
| Procept Biorobotics Corporation | $30.93 | 2021 | |
| Bluewind Medical | $27.90 | 2024 | Revi |
| Bayer Healthcare Pharmaceuticals INC. | $25.85 | 2019 | |
| 180 Medical, INC. | $22.57 | 2024 | |
| Abc Home Medical Supply, INC. | $21.88 | 2022 | |
| Ambu INC. | $20.07 | 2020 | |
| Ethicon US, LLC | $18.37 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $18.32 | 2021 | |
| Urogen Pharma, INC. | $18.09 | 2025 | |
| Travere Therapeutics, INC. | $17.60 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.21 | 2023 | |
| Tolmar, INC. | $13.90 | 2024 | |
| Astellas Pharma US INC | $12.83 | 2019 | |
| Pfizer INC. | $11.50 | 2020 | |
| Allergan, INC. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Fallen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.